A cost-minimising analysis of standard radiotherapy and two experimental therapies in glioblastoma

Radiotherapy and Oncology

Volumn 62, Issue 2, 2002, Pages 227-231

  Johannesen, Tom B ^a   Norum, Jan ^b   Lote, Knut ^a   Scheie, David ^a   Hirschberg, Henry ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Accelerated; Brachytherapy; Cost; Glioblastoma; Hospitalisation; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; FEMALE; GLIOBLASTOMA; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0036216766     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00495-9     Document Type: Article

References (28)

1. Quality-of-life issues in patients with malignant gliomas
2. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration
3. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: Accelerated radiotherapy in high-grade glioma
4. Accelerated hyperfractionated radiotherapy for malignant gliomas
5. Long-term survival in patients with glioblastoma multiforme
6. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
7. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA
8. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins
9. Prognostic factors for glioblastoma multiforme - Development of a prognostic index
10. The incidence of primary central nervous system neoplasms before and after computerized tomography availability
11. Intracavity fractionated balloon brachytherapy in glioblastoma
12. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group
13. Radiation therapy for neoplasms of the brain
14. Patterns of second recurrence of malignant astrocytomas
15. Long-term survivors of glioblastoma multiforme: Clinical and molecular characteristics
16. Radiotherapy costs in glioblastoma: A cost effective analysis
17. Prevention of colorectal cancer: A cost-effectiveness approach to a screening model employing sigmoidoscopy
18. Breast cancer screening by mammography in Norway. Is it cost-effective?
19. The morbidity and mortality of brain tumors. A perspective on recent advances in therapy
20. High-grade astrocytomas: Resource use, clinical outcomes, and cost of care
21. Five-hundred life-saving interventions and their cost-effectiveness
22. Costs-proceeds calculation for radiotherapy; comment
23. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial
24. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
25. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma